Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

• Status: Not yet recruiting
• Trial end date: 2021-09-30
• Target enrollment: 0
• Participant gender: Female

Summary

To compare the effectiveness of Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aswan University Hospital
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• patients with an indication for office hysteroscopy

Exclusion Criteria:

• patient refuse to participant

• contraindication for lidocaine patch